It was found that cancer cells with MMR activation can lead to cell cycle arrest in the G2 phase, while MMR deficiency leads to reduced G2/M cell cycle arrest and reduced activation of the p53 pathway [32, 58]. The gene discussed is TP53; the disease is cancer.